(19)
(11) EP 2 051 737 A2

(12)

(88) Date of publication A3:
03.04.2008

(43) Date of publication:
29.04.2009 Bulletin 2009/18

(21) Application number: 07796994.7

(22) Date of filing: 24.07.2007
(51) International Patent Classification (IPC): 
A61K 47/12(2006.01)
A61K 9/08(2006.01)
A61K 9/12(2006.01)
A61K 9/16(2006.01)
A61K 31/506(2006.01)
A61K 9/10(2006.01)
A61K 9/14(2006.01)
A61K 9/00(2006.01)
(86) International application number:
PCT/US2007/016637
(87) International publication number:
WO 2008/013807 (31.01.2008 Gazette 2008/05)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR
Designated Extension States:
AL BA HR MK RS

(30) Priority: 26.07.2006 US 833442 P

(71) Applicant: Merck & Co., Inc.
Rahway, NJ 07065-0907 (US)

(72) Inventor:
  • DUBOST, David, C.
    Rahway, New Jersey 07065-0907 (US)

(74) Representative: Hussain, Deeba 
Merck & Co., Inc. Hertford Road
Hoddesdon Hertfordshire EN11 9BU
Hoddesdon Hertfordshire EN11 9BU (GB)

   


(54) A NOVEL LACTIC ACID FORMULATION OF MK-0457 USEFUL FOR THE TREATMENT OF CANCER